NEW YORK, May 21, 2018 /PRNewswire/ -- In Situ
Hybridization (ISH) Market Size, Share & Trends Analysis Report
By Technology (FISH, CISH), By Type (DNA, RNA) By Product
(Instruments, Probes & Kits), By Application, By End Use, And
Segment Forecasts, 2018 - 2025
Read the full report: https://www.reportlinker.com/p05399311
The global in situ hybridization (ISH) market size is expected to
reach USD 1.84 billion by 2025,
according to a new report by Grand View Research, Inc., registering
a 7.3% CAGR during the forecast period. Increasing demand for
molecular diagnostic tools in clinical research and diagnosis is
anticipated to fuel demand for ISH in the coming years. Real-time
and automated diagnostic kits for accurate and rapid diagnosis of
cytogenetic modifications is boosting the growth prospects of the
market.
Market penetration of Fluorescent In Situ Hybridization (FISH)
probe in cancer diagnostics is the highest in the current scenario,
which is contributing to its largest revenue share.Increasing
R&D pertaining to the application of ISH in genetic diseases
and testing of infectious diseases is expected to drive the market
in the near future.
For instance, in 2016, Oxford Gene Technology expanded its
portfolio of Cytocell Aquarius FISH probes for pathology.
Further key findings from the report suggest:
• FISH held the dominant share in terms of revenue as of 2016 owing
to increase in its application in molecular diagnostics
• The DNA probes segment accounted for the largest revenue share
owing to extensive usage in clinical research and diagnosis
• RNA probes are expected to witness lucrative CAGR in the coming
years due to advantages associated with their use such as increased
stability and low cost
• ISH services are anticipated to witness exponential growth over
the forecast period owing to increase in demand for outsourcing of
molecular biology services by researchers and pathologists
• At present, the adoption of ISH in cancer diagnostics held the
dominant revenue share due to widespread application of ISH probe
technology in cancer research and diagnosis
• Contract research organizations are expected to exhibit fastest
growth during the forecast period owing to rising demand for
molecular and cytogenetic services in clinical studies
• Research and diagnostic laboratories accounted for the largest
revenue share as these systems are most commonly used in diagnosis
and research studies for the detection of chromosomal abnormalities
in various disease conditions
• North America held a majority
share of the revenue due to presence of well-established diagnostic
companies, coupled with high adoption of molecular diagnostic tools
by researchers in this region
• Asia Pacific is expected to
exhibit lucrative growth owing to increase in investments by
governments to support the growth of the biotechnology sector
• The market is facing extensive competition as there are a large
number of players offering ISH probe technology for various
applications.
Read the full report: https://www.reportlinker.com/p05399311
About Reportlinker
ReportLinker is an award-winning market research solution.
Reportlinker finds and organizes the latest industry data so you
get all the market research you need - instantly, in one place.
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
View original
content:http://www.prnewswire.com/news-releases/the-global-in-situ-hybridization-ish-market-size-is-expected-to-reach-usd-1-84-billion-by-2025--300651847.html
SOURCE Reportlinker